کد مقاله | کد نشریه | سال انتشار | مقاله انگلیسی | نسخه تمام متن |
---|---|---|---|---|
8523380 | 1557793 | 2018 | 38 صفحه PDF | دانلود رایگان |
عنوان انگلیسی مقاله ISI
Disulfiram can inhibit MERS and SARS coronavirus papain-like proteases via different modes
دانلود مقاله + سفارش ترجمه
دانلود مقاله ISI انگلیسی
رایگان برای ایرانیان
کلمات کلیدی
N-ethylmaleimideβMEMain proteasePLproDUB6-thioguanineDeubiquitinationMPANSPddC - DDCmERs - mers هاCOV - THEβ-mercaptoethanol - β-merkaptoethanolDisulfiram - دیسولفیرامSARS - سارسMiddle East respiratory syndrome - سندرم تنفسی خاورمیانهsevere acute respiratory syndrome - سندرم شدید حاد تنفسیmycophenolic acid - مایکوفنولیک اسید، مایکوفنولاتSynergistic inhibition - مهار همکاریNEM - نهpapain-like protease - پاپائین مانند پروتئازNon-structural protein - پروتئین غیر ساختاریCoronavirus - کروناویروس
موضوعات مرتبط
علوم زیستی و بیوفناوری
ایمنی شناسی و میکروب شناسی
ویروس شناسی
پیش نمایش صفحه اول مقاله
چکیده انگلیسی
Severe acute respiratory syndrome coronavirus (SARS-CoV) emerged in southern China in late 2002 and caused a global outbreak with a fatality rate around 10% in 2003. Ten years later, a second highly pathogenic human CoV, MERS-CoV, emerged in the Middle East and has spread to other countries in Europe, North Africa, North America and Asia. As of November 2017, MERS-CoV had infected at least 2102 people with a fatality rate of about 35% globally, and hence there is an urgent need to identify antiviral drugs that are active against MERS-CoV. Here we show that a clinically available alcohol-aversive drug, disulfiram, can inhibit the papain-like proteases (PLpros) of MERS-CoV and SARS-CoV. Our findings suggest that disulfiram acts as an allosteric inhibitor of MERS-CoV PLpro but as a competitive (or mixed) inhibitor of SARS-CoV PLpro. The phenomenon of slow-binding inhibition and the irrecoverability of enzyme activity after removing unbound disulfiram indicate covalent inactivation of SARS-CoV PLpro by disulfiram, while synergistic inhibition of MERS-CoV PLpro by disulfiram and 6-thioguanine or mycophenolic acid implies the potential for combination treatments using these three clinically available drugs.
ناشر
Database: Elsevier - ScienceDirect (ساینس دایرکت)
Journal: Antiviral Research - Volume 150, February 2018, Pages 155-163
Journal: Antiviral Research - Volume 150, February 2018, Pages 155-163
نویسندگان
Min-Han Lin, David C. Moses, Chih-Hua Hsieh, Shu-Chun Cheng, Yau-Hung Chen, Chiao-Yin Sun, Chi-Yuan Chou,